ConductScience.org, home

Paper9166458

The development of new cancer therapies based on the molecular identification of cancer regression antigens.

Rosenberg SA. Cancer J Sci Am, 1995. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The development of new cancer therapies based on the molecular identification of cancer regression antigens. Papers, record 9166458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9166458

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The development of new cancer therapies based on the molecular identification of cancer regression antigens.
PubMed
Journal
Cancer J Sci Am
PubMed
Year
1995
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2006-09-25
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosenberg SAS A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Animals
Humans
Lymphocytes, Tumor-Infiltrating

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
32017381Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter.Cancer Med2020https://conductscience.org/library/papers/32017381PubMed
24329789Exploiting the curative potential of adoptive T-cell therapy for cancer.Immunol Rev2014https://conductscience.org/library/papers/24329789PubMed
10877214Gene therapy for cancer: from the laboratory to the patient.Dig Dis Sci2000https://conductscience.org/library/papers/10877214PubMed
10193685Prospects for the therapeutic use of anticancer vaccines.Drugs1999https://conductscience.org/library/papers/10193685PubMed
9862627Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.J Natl Cancer Inst1998https://conductscience.org/library/papers/9862627PubMed
9500606Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.Nat Med1998https://conductscience.org/library/papers/9500606PubMed
9392001Recent advances in the treatment of malignant melanoma with gene therapy.Mol Med1997https://conductscience.org/library/papers/9392001PubMed
9334360Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.J Exp Med1997https://conductscience.org/library/papers/9334360PubMed
9141209Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.Vaccine1997https://conductscience.org/library/papers/9141209PubMed
9101410Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.J Immunother1997https://conductscience.org/library/papers/9101410PubMed
9096367Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9096367PubMed
8976176Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.J Exp Med1996https://conductscience.org/library/papers/8976176PubMed
8938272The next wave of recombinant and synthetic anticancer vaccines.Semin Cancer Biol1995https://conductscience.org/library/papers/8938272PubMed
8642255Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.J Exp Med1996https://conductscience.org/library/papers/8642255PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9166458

GET https://conductscience.org/api/papers/v1/9166458/authors